Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Tron Inc.SRM Entertainment Reports Mixed Financial Results, Net Loss, and Strategic Acquisitions
Pasithea Therapeutics Corp.Pasithea Therapeutics Reports Mixed Financial Results, Decrease in Cash Reserves, and Strategic Developments
5E Advanced Materials, Inc.5E Advanced Materials Reports Net Loss of $12.9M, Cash Position Improves Amid Operational Challenges
4D Molecular Therapeutics, Inc.4D Molecular Therapeutics Reports Significant Financial Decline, Net Loss in Q3 2024
Viracta Therapeutics, Inc.Viracta Therapeutics Reports Financial Developments, Seeks Additional Funding Amid Ongoing Net Losses
Roadzen Inc.Roadzen Inc. Reports 23% Revenue Decline, Significant Increase in Costs and Losses in Latest Quarter
Provident Bancorp, Inc. /MD/Provident Bancorp Reports 71% Decline in Net Income, Strategic Shifts in Lending Practices
QUICKLOGIC CorpQuickLogic Reports 36% Revenue Decline in Q3, Net Loss of $2.1M, Amid Increased Investment in Product Development
Ashford Inc.Ashford Inc. Reports Mixed Q3 2024 Results with 5.5% Revenue Growth and Net Loss
Kyverna Therapeutics, Inc.Kyverna Therapeutics Reports Significant Financial Developments, Including Increased Cash Reserves and Operating Expenses
TWFG, Inc.TWFG, Inc. Reports 14.5% Revenue Growth, Net Income Decline in Q3 2024
Vaxart, Inc.Vaxart Reports Revenue Growth and Improved Operating Loss in Q3 2024
DiaMedica Therapeutics Inc.DiaMedica Therapeutics Reports Decreased Assets, Increased R&D Expenses, and Operating Losses in Q3 2024
OLD MARKET CAPITAL CorpOld Market Capital Corporation Reports Significant Revenue Growth and Strategic Developments in Latest 10-Q Filing
Mobile Infrastructure CorpMobile Infrastructure Corporation Reports 21% Revenue Growth, Net Loss Improvement in Q3 2024
electroCore, Inc.electroCore Reports 45% Revenue Growth, Improved Operational Efficiency in Q3 2024
Cardio Diagnostics Holdings, Inc.Cardio Diagnostics Reports Mixed Q3 Results, Revenue Growth and Improved Losses Amid Ongoing Liquidity Challenges
CADIZ INCCadiz Inc. Reports Significant Revenue Growth, Improved Operating Results in Latest 10-Q Filing
DNA X, Inc.Sonim Technologies Reports Significant Revenue and Profit Declines in Q3 and Nine Months Ended September 30, 2024
BT Brands, Inc.BT Brands Reports 5.2% Revenue Growth, Operating Loss Amid Rising Costs and Challenges
Vireo Growth Inc.Vireo Growth Reports 2% Revenue Growth, Narrowed Net Loss in Q3 2024
Adaptimmune Therapeutics PLCAdaptimmune Reports Significant Revenue Growth and Improved Financials in Q3 2024
ZEVRA THERAPEUTICS, INC.Zevra Therapeutics Reports Net Loss of $33.2M, Increased Expenses, and Debt in Latest Quarter
Palladyne AI Corp.Palladyne AI Corp. Reports Mixed Financial Results, Focuses on AI/ML Software Platform Development
American Oncology Network, Inc.American Oncology Network Reports 39.8% Revenue Growth, Narrowed Net Loss in Q3 2024